Top Markets
Coin of the day
IBEX Technologies Inc. IBEX Technologies Inc.

IBEX Technologies Inc.

IBT
株式のランク #29032
Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc.... Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc. specializes in the production and global distribution of enzymes tailored for biomedical applications. The company's reach extends to Canada, the United States, Germany, and the United Kingdom, as well as other international markets. Its extensive product catalog features recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, along with Chondroitinase AC and B. Furthermore, IBEX offers collagen ELISAs designed to investigate the synthesis and breakdown of connective tissue components, complementing these with collagen antibodies and diamine oxidase liquid. They are also a key provider of arthritis assays, essential for research into osteoarthritis. Beyond their product lines, IBEX delivers lyophilization services for disposable medical device parts, in addition to custom fermentation and contract manufacturing capabilities. Their diverse client base encompasses medical device fabricators, quality control facilities, producers of low molecular weight heparin, and academic research institutions.
株価
$1.05
最終同期: 2024-04-11
時価総額
$23.31M
変化(1日)
-0.01%
変化(1年)
0.00%
CA
取引 IBEX Technologies Inc. (IBT)

カテゴリー

IBEX Technologies Inc.(IBT)のP/B比率
2026 時点のP/B比率 TTM: 0
IBEX Technologies Inc. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0 です。2026 年末時点でのP/B比率は 0 でした。
IBEX Technologies Inc. の P/B 比率の履歴(2026 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH